ECMO Braile Biomédica® in COVID-19 Patients

RecruitingOBSERVATIONAL
Enrollment

30

Participants

Timeline

Start Date

September 14, 2023

Primary Completion Date

January 31, 2024

Study Completion Date

March 31, 2024

Conditions
COVID-19
Interventions
DEVICE

Patients underwent cardiorespiratory support

Patients underwent cardiorespiratory support using the Oxyprime® ECMO Braile Biomédica® Membrane Oxygenator

Trial Locations (1)

71681-603

RECRUITING

Hospital Brasília, Lago Sul

All Listed Sponsors
lead

Braile Biomedica Ind. Com. e Repr. Ltda.

INDUSTRY